UWCCC Molecular Tumor Board Registry

Recruiting now

Conditions studied: Hematologic Neoplasms, Solid Neoplasm

In brief

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Key facts

Study ID

NCT03023202

Run by

University of Wisconsin, Madison

People needed

10000

Starts

2016-03-30

Expected to finish

2029-03-01

Last updated by the study team

2026-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinically suspected or histologically confirmed solid or hematological malignancy
• Undergoing genetic testing of tumor
• Ability to understand written informed consent document
• Willingness to sign written informed consent document

You may not qualify if…

• Pediatric patients (age<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Where it is running

• University of Wisconsin Carbone Cancer Center — Madison, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.